New Dermal Filler for Chin Correction and Augmentation
Not Applicable
Completed
- Conditions
- Chin Augmentation and Correction
- Interventions
- Device: Hyaluronic Acid
- Registration Number
- NCT04631263
- Lead Sponsor
- Galderma R&D
- Brief Summary
Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GP0109 for augmentation and correction or retrusion in the chin region in Canada
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
- subject willing to comply with the requirements of the study
- subject intent to receive treatment for augmentation and correction of retrusion in the chin region
- subject with mild or moderate (grade 1 or 2) on the GCRS
Exclusion Criteria
- subjects presenting with know allergy to HA (hyaluronic acid) filler or amide local anesthetics
- subjects with any previous facial surgery below the nasal line or previous HA filler or collagen below the nasal line within 12 months
- subjects in any other interventional clinical study within 30 days before baseline
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment Group Hyaluronic Acid -
- Primary Outcome Measures
Name Time Method Responder rate based on the Galderma Chin Retrusion Scale as assessed live by the Blinded Evaluator 3 months after baseline
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Galderma Research Site
🇨🇦Westmount, Quebec, Canada